EditorialPolicy

Neglected Diseases, Delinquent Diagnostics

See allHide authors and affiliations

Science Translational Medicine  05 Mar 2014:
Vol. 6, Issue 226, pp. 226ed6
DOI: 10.1126/scitranslmed.3008194

Article Information

vol. 6 no. 226 226ed6

PubMed: 
Print ISSN: 
Online ISSN: 
History: 

    Author Information

    1. Mark Kessel
    1. Mark Kessel is chairman of the Foundation for Innovative New Diagnostics (FIND), 1202 Geneva, Switzerland; of counsel to Shearman & Sterling LLP, New York, NY 10022, USA; and a partner of Symphony Capital, New York, NY 10022, USA. E-mail: mark.kessel{at}shearman.com

    Altmetric

    Article usage

    Article usage: March 2014 to December 2017

    AbstractFullPdf
    Mar 201416501197
    Apr 201443912
    May 201403210
    Jun 20141297
    Jul 201403313
    Aug 20141175
    Sep 20141166
    Oct 2014065
    Nov 201401011
    Dec 2014095
    Jan 2015014
    Feb 201524833
    Mar 2015248
    Apr 2015062
    May 2015012
    Jun 2015025
    Jul 2015042
    Sep 2015030
    Oct 2015030
    Nov 2015056
    Dec 2015011
    Jan 2016017
    Feb 2016011
    Mar 2016082
    Apr 2016031
    May 2016043
    Jun 2016062
    Jul 2016093
    Aug 20160642
    Oct 2016032
    Nov 2016043
    Dec 2016020
    Jan 20170113
    Feb 20170103
    Mar 2017053
    Apr 2017020
    May 2017022
    Jun 2017094
    Jul 2017040
    Aug 2017040
    Sep 2017041
    Oct 2017032
    Nov 2017063
    Dec 2017010